Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy
Authors:
- B. J. AhnBAB. J. Ahn
- S. J. HanSHS. J. Han
- A. T. ParsaAPA. T. Parsa
- 9 March 2012
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 14 (5) , 584-595
Abstract
In patients with glioma, the tumor microenvironment can significantly impact pro-inflammatory immune cell functions. However, the mechanisms by which this occurs are poorly defined. Because immunosuppressive regulatory T cells (Treg) are over represented in the tumor microenvironment compared with peripheral blood, we hypothesized that the tumor may have an effect on Treg survival, migration, expansion, and/or induction of a regulatory phenotype from non-Treg conventional CD4+ T cells. We defined the impact of soluble factors produced by tumor cells on Treg from healthy patients in vitro to determine mechanisms by which gliomas influence T cell populations. We found that tumor-derived soluble factors allowed for preferential proliferation and increased chemotaxis of Treg, compared with conventional T cells, indicating that these mechanisms may contribute to the increased Treg in the tumor microenvironment. Conventional T cells also exhibited a significantly increased expression of pro-apoptotic transcripts in the presence of tumor-derived factors, indicating that survival of Treg in the tumor site is driven by exposure to soluble factors produced by the tumor. Together, these data suggest that tumor burden may induce increased Treg infiltration, proliferation, and survival, negating productive anti-tumor immune responses in patients treated with immunotherapies. Collectively, our data indicate that several mechanisms of Treg recruitment and retention in the tumor microenvironment exist and may need to be addressed to improve the specificity of immunotherapies seeking to eliminate Treg in patients with glioma.Keywords
This publication has 53 references indexed in Scilit:
- Preferential Expression of Integrin αvβ8 Promotes Generation of Regulatory T Cells by Mouse CD103+ Dendritic CellsGastroenterology, 2011
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma modelProceedings of the National Academy of Sciences, 2011
- Glioma-derived T Cell Immunoglobulin- and Mucin Domain-containing Molecule-4 (TIM4) Contributes to Tumor ToleranceJournal of Biological Chemistry, 2011
- Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumorsNeuro-Oncology, 2011
- PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastomaOncogene, 2011
- Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cellsProceedings of the National Academy of Sciences, 2011
- HSP70 Protein Promotes Survival of C6 and U87 Glioma Cells by Inhibition of ATF5 DegradationJournal of Biological Chemistry, 2011
- Reprogrammed Foxp3+ Regulatory T Cells Provide Essential Help to Support Cross-presentation and CD8+ T Cell Priming in Naive MiceImmunity, 2010
- Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapyJournal of Neuro-Oncology, 2010
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumorsProceedings of the National Academy of Sciences, 2010